Assessment of P-glycoprotein Activity in the Blood-Brain Barrier (BBB) Using Near Infrared Fluorescence (NIRF) Imaging Techniques (Q39539362)

12 September 2017

title

Assessment of P-glycoprotein activity in the Blood-Brain Barrier (BBB) using Near Infrared Fluorescence (NIRF) imaging techniques (English)

1 reference

12 September 2017

Assessment of P-glycoprotein Activity in the Blood-Brain Barrier (BBB) Using Near Infrared Fluorescence (NIRF) Imaging Techniques (English)

1 reference

DOI

https://api.crossref.org/works/10.1007/S11095-011-0478-6

2 December 2024

1 reference

Fang Chen

2

1 reference

12 September 2017

Martha Hinton

series ordinal

3

1 reference

12 September 2017

Ngoc H. On

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21598079

2 December 2024

Donald W. Miller

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21598079

2 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21598079

2 December 2024

publication date

20 May 2011

1 reference

full work available at URL

12 September 2017

http://link.springer.com/content/pdf/10.1007/s11095-011-0478-6.pdf

1 reference

https://api.crossref.org/works/10.1007/S11095-011-0478-6

http://link.springer.com/article/10.1007/s11095-011-0478-6/fulltext.html

2 December 2024

1 reference

https://api.crossref.org/works/10.1007/S11095-011-0478-6

http://link.springer.com/content/pdf/10.1007/s11095-011-0478-6

2 December 2024

1 reference

DOI

https://api.crossref.org/works/10.1007/S11095-011-0478-6

2 December 2024

published in

Pharmaceutical Research

1 reference

12 September 2017

volume

28

1 reference

12 September 2017

issue

10

1 reference

12 September 2017

page(s)

2505-2515

1 reference

Blood-brain barrier dysfunction and recovery

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S11095-011-0478-6

Developmental expression of P-glycoprotein (multidrug resistance gene product) in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11095-011-0478-6

Does inhibition of P-glycoprotein lead to drug-drug interactions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11095-011-0478-6

Multidrug efflux pumps: substrate selection in ATP-binding cassette multidrug efflux pumps--first come, first served?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11095-011-0478-6

Role of P-glycoprotein in pharmacokinetics: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11095-011-0478-6

P-glycoprotein related drug interactions: clinical importance and a consideration of disease states

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11095-011-0478-6

Quantitative assessment of HIV-1 protease inhibitor interactions with drug efflux transporters in the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11095-011-0478-6

P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11095-011-0478-6

In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11095-011-0478-6

P-glycoprotein: so many ways to turn it on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11095-011-0478-6

Over-expression of P-glycoprotein in the canine brain following spontaneous status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11095-011-0478-6

Rifampin and digoxin induction of MDR1 expression and function in human intestinal (T84) epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11095-011-0478-6

Synthesis and small-animal positron emission tomography evaluation of [11C]-elacridar as a radiotracer to assess the distribution of P-glycoprotein at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11095-011-0478-6

Pharmacoresistance in epilepsy: a pilot PET study with the P-glycoprotein substrate R-[(11)C]verapamil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11095-011-0478-6

Current advances in molecular imaging: noninvasive in vivo bioluminescent and fluorescent optical imaging in cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11095-011-0478-6

Whole-body optical imaging in animal models to assess cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11095-011-0478-6

Near-infrared fluorescent probes for imaging vascular pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11095-011-0478-6

Near-infrared fluorescence: application to in vivo molecular imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11095-011-0478-6

The multi-drug resistance reversal agent SR33557 and modulation of vinca alkaloid binding to P-glycoprotein by an allosteric interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11095-011-0478-6

Role of blood-brain barrier P-glycoprotein in limiting brain accumulation and sedative side-effects of asimadoline, a peripherally acting analgaesic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11095-011-0478-6

ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11095-011-0478-6

Role of multidrug transporters in pharmacoresistance to antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11095-011-0478-6

Near-infrared investigations of novel anti-HIV tenofovir liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11095-011-0478-6

Use of rhodamine 123 to examine the functional activity of P-glycoprotein in primary cultured brain microvessel endothelial cell monolayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11095-011-0478-6

In vitro and in vivo models for assessing drug efflux transporter activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11095-011-0478-6

P-glycoprotein-mediated active efflux of the anti-HIV1 nucleoside abacavir limits cellular accumulation and brain distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11095-011-0478-6

Membrane transporters in drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11095-011-0478-6

Characterization of the ATPase activity of purified Chinese hamster P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11095-011-0478-6

(R)-[11C]verapamil PET studies to assess changes in P-glycoprotein expression and functionality in rat blood-brain barrier after exposure to kainate-induced status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11095-011-0478-6

Image-guided oncologic surgery using invisible light: completed pre-clinical development for sentinel lymph node mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11095-011-0478-6

Blood-brain barrier transporters and response to CNS-active drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11095-011-0478-6

Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11095-011-0478-6

Potential role of ABC transporters as a detoxification system at the blood-CSF barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11095-011-0478-6

Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11095-011-0478-6

Transporter-mediated drug interactions: clinical implications and in vitro assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11095-011-0478-6

Transepithelial transport of drugs by the multidrug transporter in cultured Madin-Darby canine kidney cell epithelia

21 January 2018

1 reference

12 December 2020

Effect of the p-glycoprotein inhibitor, cyclosporin A, on the distribution of rhodamine-123 to the brain: an in vivo microdialysis study in freely moving rats

1 reference

12 December 2020

Rational use of in vitro P-glycoprotein assays in drug discovery

1 reference

12 December 2020

Transport of rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytochrome P-450 3A-related compounds

1 reference

12 December 2020

Cytotoxic effects of adriamycin on the central nervous system of the mouse--cytofluorescence and electron-microscopic observations after various modes of administration

1 reference

12 December 2020

Comparison of drug efflux transport kinetics in various blood-brain barrier models

1 reference

12 December 2020

The expression of multidrug resistance-associated protein (MRP) in pancreatic adenocarcinoma cell lines

1 reference

12 December 2020

Membrane transporter proteins: a challenge for CNS drug development.

1 reference

12 December 2020

Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging

1 reference

12 December 2020

Identifiers

DOI

1 reference

release_yveeogbbe5h7liyzt4hthhdmiy

12 September 2017

Fatcat ID

0 references

1 reference